AROA BIOSURGERY LIMITED — Director's Dealing 2025

Jun 10, 2025

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Aroa Biosurgery Limited ARBN 638 867 473

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	John Diddams
Date of last notice	31 March 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest		Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.		Whitfield Investments Pty Ltd Diddams Family Trust> (Beneficiary) Galdarn Pty Ltd (Beneficiary)
Date of change		6 June 2025
No. of securities held prior to change		Indirect Whitfield Investments Pty Ltd _Diddams Family Trust> 1,028,675 Fully Paid Ordinary Shares 20,452 Options exercisable at A$1.07 expiring 30 November 2027 172,620 Options exercisable at $1.083 expiring 29 February 2028 Galdarn Pty Ltd 163,875 Fully Paid Ordinary Shares Mr Diddams transferred 100,000 fully paid ordinary shares from Galdarn Pty Ltd to Whitfield Investments Pty Ltd since his last Appendix 3Y was lodged on 31 March 2023.

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class	Fully Paid Ordinary Shares
Number acquired	Nil
Number disposed	160,000
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$77,474.96
No. of securities held after change	Indirect Whitfield Investments Pty Ltd _Diddams Family Trust> 1,028,675 Fully Paid Ordinary Share 20,452 Options exercisable at A$1.07 expiring 30 November 2027 172,620 Options exercisable at $1.083 expiring 29 February 2028 Galdarn Pty Ltd 3,875 Fully Paid Ordinary Shares
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back	On market sale

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change	-
	-
	-
	-
	-
	-
	-
	-
	-

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3